Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TBPH | Theravance Biopharma, Inc. | Director | $696 K | May 8, 2024 | ||
CERT | Certara, Inc. | Director | $621 K | +$79.1 K | +14.6% | May 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|